Literature DB >> 31040231

Mogamulizumab versus investigator choice in relapsed/refractory adult T-cell leukemia/lymphoma: all four one or none for all?

William Johnson1, Anjali Mishra1, Adam Binder1, Alejandro Gru2, Pierluigi Porcu1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31040231      PMCID： PMC6518897          DOI： 10.3324/haematol.2018.214536

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  22 in total

Review 1.  HTLV-1 infections.

Authors:  C R Bangham
Journal:  J Clin Pathol       Date:  2000-08       Impact factor: 3.411

2.  CCR4 mutations associated with superior outcome of adult T-cell leukemia/lymphoma under mogamulizumab treatment.

Authors:  Yuma Sakamoto; Takashi Ishida; Ayako Masaki; Takayuki Murase; Kentaro Yonekura; Yukie Tashiro; Masahito Tokunaga; Atae Utsunomiya; Asahi Ito; Shigeru Kusumoto; Shinsuke Iida; Ryuzo Ueda; Hiroshi Inagaki
Journal:  Blood       Date:  2018-06-21       Impact factor: 22.113

3.  A critical analysis of prognostic factors in North American patients with human T-cell lymphotropic virus type-1-associated adult T-cell leukemia/lymphoma: a multicenter clinicopathologic experience and new prognostic score.

Authors:  Adrienne A Phillips; Iuliana Shapira; Robert D Willim; Jasotha Sanmugarajah; William B Solomon; Steven M Horwitz; David G Savage; Govind Bhagat; Gerald Soff; Jasmine M Zain; Bachir Alobeid; Venkatraman E Seshan; Owen A O'Connor
Journal:  Cancer       Date:  2010-07-15       Impact factor: 6.860

4.  Epidemiology, clinical features, and outcome of HTLV-1-related ATLL in an area of prevalence in the United States.

Authors:  Luis Malpica; Agustin Pimentel; Isildinha M Reis; Eduardo Gotuzzo; Lazaros Lekakis; Krishna Komanduri; Thomas Harrington; Glen N Barber; Juan C Ramos
Journal:  Blood Adv       Date:  2018-03-27

5.  VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801.

Authors:  Kunihiro Tsukasaki; Atae Utsunomiya; Haruhiko Fukuda; Taro Shibata; Takuya Fukushima; Yoshifusa Takatsuka; Shuichi Ikeda; Masato Masuda; Haruhisa Nagoshi; Ryuzo Ueda; Kazuo Tamura; Masayuki Sano; Saburo Momita; Kazunari Yamaguchi; Fumio Kawano; Shuichi Hanada; Kensei Tobinai; Masanori Shimoyama; Tomomitsu Hotta; Masao Tomonaga
Journal:  J Clin Oncol       Date:  2007-10-29       Impact factor: 44.544

6.  Treatment and survival among 1594 patients with ATL.

Authors:  Hiroo Katsuya; Kenji Ishitsuka; Atae Utsunomiya; Shuichi Hanada; Tetsuya Eto; Yukiyoshi Moriuchi; Yoshio Saburi; Masaharu Miyahara; Eisaburo Sueoka; Naokuni Uike; Shinichiro Yoshida; Kiyoshi Yamashita; Kunihiro Tsukasaki; Hitoshi Suzushima; Yuju Ohno; Hitoshi Matsuoka; Tatsuro Jo; Masahiro Amano; Ryosuke Hino; Mototsugu Shimokawa; Kazuhiro Kawai; Junji Suzumiya; Kazuo Tamura
Journal:  Blood       Date:  2015-09-11       Impact factor: 22.113

7.  Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: a randomized phase II study.

Authors:  Takashi Ishida; Tatsuro Jo; Shigeki Takemoto; Hitoshi Suzushima; Kimiharu Uozumi; Kazuhito Yamamoto; Naokuni Uike; Yoshio Saburi; Kisato Nosaka; Atae Utsunomiya; Kensei Tobinai; Hiroshi Fujiwara; Kenji Ishitsuka; Shinichiro Yoshida; Naoya Taira; Yukiyoshi Moriuchi; Kazunori Imada; Toshihiro Miyamoto; Shiro Akinaga; Masao Tomonaga; Ryuzo Ueda
Journal:  Br J Haematol       Date:  2015-03-02       Impact factor: 6.998

8.  HTLV-1 HBZ Viral Protein: A Key Player in HTLV-1 Mediated Diseases.

Authors:  Marco Baratella; Greta Forlani; Roberto S Accolla
Journal:  Front Microbiol       Date:  2017-12-22       Impact factor: 5.640

9.  Mogamulizumab for relapsed adult T-cell leukemia-lymphoma: Updated follow-up analysis of phase I and II studies.

Authors:  Takashi Ishida; Atae Utsunomiya; Tatsuro Jo; Kazuhito Yamamoto; Koji Kato; Shinichiro Yoshida; Shigeki Takemoto; Hitoshi Suzushima; Yukio Kobayashi; Yoshitaka Imaizumi; Kenichi Yoshimura; Kouichi Kawamura; Takeshi Takahashi; Kensei Tobinai; Ryuzo Ueda
Journal:  Cancer Sci       Date:  2017-08-28       Impact factor: 6.716

Review 10.  Adult T Cell Leukemia-Lymphoma (ATL): State of the Art.

Authors:  Adrienne A Phillips; Janine C K Harewood
Journal:  Curr Hematol Malig Rep       Date:  2018-08       Impact factor: 4.213
View more
  1 in total

Review 1.  Updates in lymph node and skin pathology of adult T-cell leukemia/lymphoma, biomarkers, and beyond.

Authors:  Brian D Adkins; Juan C Ramos; Meghan Bliss-Moreau; Alejandro A Gru
Journal:  Semin Diagn Pathol       Date:  2019-12-20       Impact factor: 3.464
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.